Reactive oxygen and nitrogen species
The client narrative around RONS is almost entirely wrong. “Free radicals damage skin; antioxidants prevent that damage” is a framing so compressed it becomes inaccurate – and the inaccuracy matters clinically, because the same reactive species that accelerate photoageing at high concentrations are the signalling molecules that initiate the collagen remodelling cascade after a microneedling session, the antimicrobial agents that sterilise a wound, the vasodilatory NO molecules that support healing angiogenesis, and the entire mechanism of action of cold atmospheric plasma. RONS are not skin’s enemies. They are the redox language through which skin cells communicate about damage, repair, threat, and renewal. The concentration, the species, the location, and the duration of exposure are everything.
The NRF2 antioxidant defence system – the cell’s primary sensor and responder to RONS – is itself activated by low-level ROS. The defence is triggered by the very thing it defends against, at concentrations below the damage threshold. This is the hormetic principle, and it is what makes therapeutic procedures that deliberately generate controlled RONS mechanistically coherent rather than paradoxical. Every practitioner working with CAP, RF microneedling, or laser resurfacing needs a working model of RONS biology – not because the science is needed at the treatment couch, but because clients ask about antioxidants, sun protection, and supplement timing and deserve answers that are accurate, specific, and grounded in something more than “free radicals are bad.”
The dose-response relationship – the organising principle
RONS are not uniformly harmful. They are chemically reactive molecules that act on biological targets – and like every signalling molecule, what they do depends entirely on how much of them is present, where, and for how long. At the low concentrations of normal cellular metabolism, ROS and RNS are second messengers: they activate transcription factors, stabilise hypoxia-inducible proteins, regulate enzyme activity, and coordinate immune responses. At the higher concentrations produced by UV overexposure, chronic inflammation, or dysbiotic microbial activity, the same species outpace the cell’s antioxidant defence capacity, producing cumulative oxidative damage to DNA, membrane lipids, and structural proteins. [6]
This dose-response curve is non-linear and biphasic – a pattern called hormesis. The beneficial zone is not zero RONS; it is a controlled low-to-moderate concentration where reactive species activate repair and defence pathways without exceeding the clearance capacity of antioxidant enzymes. Therapeutic procedures that generate controlled RONS – cold atmospheric plasma, RF microneedling, fractional laser resurfacing – are operating deliberately in this hormetic zone. They are not side-stepping the RONS biology; they are using it. Understanding this is the precondition for every other clinical insight this entity provides.
The three transcription factors most directly regulated by RONS concentration form the signalling backbone of this entity:
| Transcription factor | Activated by | Primary downstream output | RONS zone |
|---|---|---|---|
| NRF2 | Low–moderate H₂O₂ via Keap1 cysteine oxidation | SOD, catalase, GPx, HMOX1, NQO1, GCL – antioxidant defence and cytoprotection | Physiological–therapeutic |
| NF-κB | Moderate–high ROS; NOX-induced amplification loop | TNF-α, IL-6, IL-1β, MMP production; generates further ROS through NOX induction | High/pathological |
| AP-1 (c-Jun/c-Fos) | ROS via MAPK cascade – ERK, JNK, p38 | MMP-1, MMP-3, MMP-9 expression; collagen I/III degradation | High/pathological |
The relationship between these three is concentration-dependent. Low ROS → primarily NRF2 activation → antioxidant defence, cytoprotection. Moderate-to-high ROS → NF-κB and AP-1 activation → inflammation, MMP production, collagen degradation. Therapeutic RONS targets the NRF2 zone. Chronic sun exposure and uncontrolled inflammation operate in the NF-κB/AP-1 zone.
The NRF2 antioxidant defence system
NRF2 (Nuclear Factor Erythroid 2-Related Factor 2) is the transcription factor that coordinates the cell’s response to oxidative stress – and unlike most stress response systems, it is not dormant until needed. It is constitutively active at a basal level, with its activity continuously modulated by the ambient ROS concentration in the cell. [5]
Under resting conditions, NRF2 is held in the cytoplasm by its repressor protein Keap1 (Kelch-like ECH-associated protein 1), which binds NRF2 and targets it for continuous ubiquitin-mediated proteasomal degradation. Keap1 functions as the ROS sensor: it contains reactive cysteine residues – particularly C151, C273, and C288 – whose thiol groups are oxidised or modified by ROS and electrophilic compounds. When RONS concentrations rise, these cysteines are modified, Keap1’s E3 ligase adaptor function is disrupted, NRF2 is no longer ubiquitinated and degraded, and it accumulates in the cytoplasm. It then translocates to the nucleus, heterodimerises with small Maf proteins, and binds the Antioxidant Response Element (ARE) sequence in the promoters of its target genes. [5]
NRF2 target genes relevant to skin
| Gene | Protein | Reaction / substrate | Skin-specific relevance |
|---|---|---|---|
| HMOX1 | Haem oxygenase-1 | Degrades haem → biliverdin + CO | CO: anti-inflammatory, vasodilatory; strongly upregulated by CAP |
| NQO1 | NAD(P)H quinone oxidoreductase 1 | Two-electron quinone reduction | Stabilises p53; UV-induced DNA damage protection |
| SOD1/2/3 | Superoxide dismutases | O₂·⁻ → H₂O₂ | SOD2 (mitochondrial): direct target of V. filiformis/TLR2/NRF2 signalling |
| Catalase | Catalase | H₂O₂ → H₂O + O₂ | Primary H₂O₂ clearance; peroxisomal; rate-limiting at high H₂O₂ loads |
| GPx1–4 | Glutathione peroxidases | H₂O₂ + lipid hydroperoxides + GSH → GSSG | GPx4 specifically protective against lipid peroxidation chain reactions |
| GCL | Glutamate-cysteine ligase | Rate-limiting step in GSH synthesis | NRF2-driven GCL induction expands total antioxidant capacity |
| TrxR | Thioredoxin reductase | Reduces thioredoxin → reduces oxidised protein cysteines | Supplies electrons to peroxiredoxins; supports thiol redox homeostasis |
The NRF2/Keap1/ARE axis declines with age in skin keratinocytes and fibroblasts – basal NRF2 nuclear occupancy decreases, Keap1 expression increases, and the magnitude of the antioxidant response to a given ROS stimulus progressively diminishes. This age-related NRF2 decline is one mechanistic reason why older skin is more vulnerable to UV-induced oxidative damage, recovers more slowly from procedural stress, and accumulates MMP-driven matrix degradation faster than younger skin at equivalent UV exposure. [2] [5]
Reactive oxygen species
ROS are oxygen-derived molecules carrying unpaired electrons or capable of generating them. Four species are primary in skin biology:
Superoxide (O₂·⁻)
The primary ROS product of cellular metabolism – generated by the incomplete one-electron reduction of molecular oxygen at mitochondrial Complex I and Complex III during ATP synthesis, and by NADPH oxidase (NOX) enzyme complexes in the plasma membrane. O₂·⁻ itself is relatively membrane-impermeant and short-lived, but it is the precursor of the more biologically significant H₂O₂ (via SOD dismutation) and the highly damaging peroxynitrite (via reaction with NO). NOX enzymes in skin keratinocytes (NOX1, NOX4) are the primary source of extramitochondrial O₂·⁻, activated by growth factor signalling, cytokine stimulation, and mechanical stress – including the mechanical microtrauma of microneedling. [11]
Hydrogen peroxide (H₂O₂)
The most stable and most biologically significant ROS signal. Unlike O₂·⁻, H₂O₂ is membrane-permeable – it crosses cell membranes through aquaporin channels (particularly AQP3 and AQP8) and can therefore act as a diffusible second messenger between cells. At nanomolar-to-low-micromolar concentrations, H₂O₂ activates NRF2 (via Keap1 cysteine oxidation), modulates NF-κB, and coordinates wound healing responses through PI3K/Akt and MAPK pathway activation. At higher concentrations it drives the Fenton reaction (see below) and protein oxidation (cysteine and methionine sulfoxidation, carbonylation). H₂O₂ is the primary antimicrobial species in CAP output and the species primarily responsible for CAP-mediated NF-κB modulation in rosacea and AD skin. [8]
Hydroxyl radical (·OH)
The most reactive and most damaging ROS – generated by the Fenton reaction: Fe²⁺ + H₂O₂ → Fe³⁺ + ·OH + OH⁻. Because ·OH reacts within nanoseconds of generation, essentially at its point of production, it produces highly localised damage – DNA strand breaks (8-OHdG formation), membrane lipid peroxidation chain reactions, and irreversible protein carbonylation. There is no enzymatic scavenger for ·OH; the antioxidant defence against it operates indirectly by maintaining low H₂O₂ concentrations and limiting free iron availability. Melanin acts as a ·OH scavenger in UV-exposed epidermal keratinocytes – one functional role of melanin that extends beyond simple UV light absorption. [12]
Singlet oxygen (¹O₂)
An excited-state oxygen molecule generated principally by UV irradiation in the presence of endogenous photosensitisers (porphyrins, flavins, melanin intermediates) and by certain plasma discharge reactions in CAP. ¹O₂ has a short lifetime in aqueous environments (microseconds) but reacts rapidly with guanine bases in DNA and with polyunsaturated fatty acids in membrane phospholipids. In photoageing, ¹O₂ contributes to the 8-OHdG DNA damage signature and to lipid peroxidation-mediated membrane disruption. [12]
Reactive nitrogen species
RNS are nitrogen-derived reactive molecules whose biology in skin is dominated by nitric oxide (NO) and its downstream chemistry. They are not simply a parallel category to ROS – at higher concentrations they intersect directly through peroxynitrite formation, making the ROS/RNS boundary functionally blurred in inflamed tissue.
Nitric oxide (NO). A short-lived, membrane-permeable gas synthesised by three nitric oxide synthase (NOS) isoforms present in skin: [14]
| Isoform | Expression in skin | Primary function | Clinical relevance |
|---|---|---|---|
| eNOS (NOS3) | Dermal endothelial cells, keratinocytes; constitutive | Tonic vasodilation via sGC/cGMP/PKG | Baseline dermal perfusion; vasodilatory response at wound sites; mimicked by CAP-derived NO |
| nNOS (NOS1) | Cutaneous sensory nerve fibres; constitutive | Neuropeptide-independent vasoregulation; neural sensitisation signalling | Neurogenic inflammation interface; contributes to the SP/CGRP/vascular axis |
| iNOS (NOS2) | Not constitutive; induced by NF-κB in response to LPS, IFN-γ, IL-1β, TNF-α | High-output NO (μM range); antimicrobial | Directly induced by CAP treatment; primary antimicrobial NO source at wound sites |
NO’s biological effects are concentration-dependent in the same way as ROS: at eNOS-level concentrations (pM–nM range), NO is vasodilatory, cytoprotective, and pro-angiogenic; at iNOS-level concentrations (μM range), it contributes to inflammatory cytotoxicity and can react with O₂·⁻ to form peroxynitrite. [14] [13]
NO and melanogenesis
NO generated by keratinocyte NOS directly stimulates melanogenesis through a tyrosinase-dependent mechanism, and acts on melanocytes to increase TYRP1 (tyrosinase-related protein 1) expression and melanin output. UV-induced keratinocyte NO production contributes to the post-UV tanning response through this paracrine pathway. In the context of treatments that generate or modulate NO – including CAP and LED photobiomodulation – the melanogenic potential of the NO signal is worth noting in clients with melasma or post-inflammatory hyperpigmentation risk, particularly with higher-energy or higher-frequency treatment schedules. [14]
Peroxynitrite (ONOO⁻)
The convergence point of ROS and RNS chemistry – formed by the near-diffusion-limited reaction of superoxide (O₂·⁻) with nitric oxide (NO): O₂·⁻ + NO → ONOO⁻. Peroxynitrite is more reactive than either precursor. It nitrates protein tyrosine residues (3-nitrotyrosine formation – a marker of nitrosative stress detectable in tissue biopsies), oxidises methionine and cysteine residues, and causes DNA single-strand breaks. Critically, ONOO⁻ formation is preferential at high ROS/RNS concentrations – it becomes the dominant product when both O₂·⁻ and NO are being generated simultaneously at elevated levels. In chronically inflamed skin where NOX-derived O₂·⁻ and iNOS-derived NO are both elevated, ONOO⁻ production becomes a genuine pathological species contributing to matrix damage and sustained inflammatory signalling, distinct from either oxidative or nitrosative stress alone. [10]
NO₂ and HNO₂ (nitrous acid)
Secondary RNS formed from NO oxidation in aqueous environments. Less physiologically prominent than NO and ONOO⁻ in skin biology, but relevant in CAP plasma chemistry where NO₂ and HNO₂ are measurable components of the reactive species output and contribute to the acidified aqueous environment that has antimicrobial properties at the treatment surface. [8]
RONS in skin ageing
The progressive accumulation of oxidative damage over a lifetime is one of the primary drivers of intrinsic skin ageing – and the UV-driven amplification of that accumulation is the primary driver of photoageing. The mechanism is not simply that ROS “damage” the skin; it is that specific ROS-activated signalling pathways produce specific, predictable structural changes that are visible, palpable, and progressive. [9]
The UV/MAPK/AP-1/MMP axis
UV irradiation (UVB particularly) generates ROS in keratinocytes and fibroblasts within seconds of exposure, activating three MAPK kinase cascades simultaneously – ERK, JNK, and p38. All three converge on AP-1 transcription factor assembly. AP-1 (c-Jun/c- Fos) drives expression of MMP-1 (interstitial collagenase – cleaves native fibrillar collagen I and III), MMP-3 (stromelysin – degrades fibronectin, laminin, proteoglycans), and MMP-9 (gelatinase B – degrades denatured collagen and elastin). A single minimal erythemal UV dose produces measurable collagenase activity in sun-exposed skin within hours. Repeated UV exposures do not allow full MMP clearance and collagen resynthesis between them – the deficit accumulates, the collagen and elastin matrix progressively degrades, and the structural thinning, laxity, and rhytid formation of photoageing results. [7] [7]
The mitochondrial ROS perpetuation cycle
Mitochondria are both the primary endogenous source of ROS and the primary target of ROS damage in ageing skin. Mitochondrial Complex I and Complex III generate O₂·⁻ as a normal byproduct of electron transport. With age, accumulating mitochondrial DNA damage (from decades of ROS exposure, with mitochondrial DNA particularly vulnerable due to its proximity to the electron transport chain and relative lack of protective histones) impairs electron transport chain efficiency – producing more electron leak, more O₂·⁻ generation per unit ATP synthesised, and further mitochondrial DNA damage. This self-amplifying cycle progressively increases the mitochondrial ROS baseline in dermal fibroblasts over time, elevating the AP-1/NF-κB signalling environment without any external UV trigger. Age-related intrinsic skin changes – fibroblast functional decline, reduced procollagen synthesis, increased baseline MMP expression – are partly explained by this progressive mitochondrial ROS escalation operating independently of sun exposure. [1] [9]
Fibroblast senescence and SASP
Chronic ROS exposure – from the mitochondrial perpetuation cycle, from UV accumulation, and from sustained inflammatory cytokine environments – drives dermal fibroblasts into a senescent state: irreversible cell cycle arrest accompanied by the Senescence-Associated Secretory Phenotype (SASP). Senescent fibroblasts secrete IL-6, IL-8, TNF-α, MMP-1, MMP-3, and further ROS into their tissue microenvironment – a pro-inflammatory, pro-degradative output that compromises neighbouring healthy fibroblasts and accelerates matrix breakdown around the senescent cell. SASP-driven ROS then promote further fibroblast senescence in adjacent cells, propagating senescence as a spreading tissue state rather than a contained cellular event. This is the mechanism linking accumulated oxidative stress to the “spreading slowness” of aged skin’s repair response – not individual fibroblasts failing, but a growing population of senescent cells actively degrading the ECM around them. [7] [3]
RONS in wound healing
The wound healing role of RONS is the clearest demonstration of the dose-response principle in action. The acute ROS burst at a fresh wound site is not an unfortunate side effect of tissue damage – it is a coordinated signalling event that initiates the healing programme. [11]
Within seconds of barrier disruption, NADPH oxidase (NOX1 and NOX2) generates a sustained O₂·⁻ burst at the wound edge – rapidly dismutated to H₂O₂, which diffuses into the wound margin as a chemotactic gradient. Keratinocytes and fibroblasts at the wound edge sense this H₂O₂ gradient through redox-sensitive receptor tyrosine kinases and PI3K/Akt pathway activation, triggering proliferation and migration toward the wound centre. Simultaneously: [11] [4]
- H₂O₂ stabilises HIF-1α (hypoxia-inducible factor) → VEGF transcription → angiogenic ingrowth
- H₂O₂ directly kills bacteria in the wound environment, providing immediate antimicrobial defence before the adaptive immune response arrives
- iNOS induction by wound-site cytokines (IFN-γ, LPS from contaminating bacteria, IL-1β) produces NO → sustained vasodilation maintaining blood flow, collagen crosslinking via NO-modified prolines, and further VEGF signalling
- eNOS-derived NO in endothelial cells produces the vascular smooth muscle relaxation that sustains the increased perfusion at the healing site
The contrast with chronic wound biology is instructive. In chronic wounds – diabetic ulcers, venous leg ulcers – RONS are present at high concentrations rather than controlled acute-phase concentrations. NADPH oxidase is constitutively activated, the antioxidant defence capacity is depleted, and the persistent high-ROS environment activates NF-κB continuously, maintains elevated MMP-9, degrades the provisional matrix as fast as it forms, impairs keratinocyte migration, and prevents re-epithelialisation. The same H₂O₂ that initiates healing at acute concentrations destroys it at chronic excess concentrations. [11]
This acute/chronic distinction is directly relevant to procedure planning. Stimulatory aesthetic procedures – RF microneedling, fractional laser, CAP – produce the acute RONS burst biology in controlled, localised form. Pre-existing chronic low-grade inflammation (uncontrolled rosacea, active AD, poorly managed barrier disruption) shifts the baseline RONS environment at the treatment site toward the chronic wound end of the spectrum before the procedure begins – compromising the clean acute-phase response that produces the remodelling benefit.
CAP as therapeutic RONS delivery
Cold atmospheric plasma occupies a unique position in aesthetic medicine: it is the only treatment modality that delivers precisely calibrated RONS directly to the tissue surface as its primary mechanism of action, rather than generating RONS as a secondary consequence of energy delivery. [8]
RONS composition of CAP output
CAP generates a defined mixture of reactive species from the ionisation of ambient air or carrier gas during plasma discharge. The primary therapeutically relevant species are: [8] [8]
| Species | Generation in CAP | Primary therapeutic mechanism | Tissue penetration |
|---|---|---|---|
| H₂O₂ | Plasma–liquid interface | Antimicrobial; NF-κB modulation; Keap1 oxidation → NRF2 → HMOX1/NQO1 | Penetrates into epidermis via AQP channels |
| NO | Atmospheric N₂ ionisation in plasma discharge | Vasodilation (eNOS-mimetic); VEGF signalling; collagen synthesis | Short-range diffusion; acts within treated tissue |
| ONOO⁻ | NO + O₂·⁻ at plasma/tissue interface | Antimicrobial; activates signalling at therapeutic concentrations without chronic nitrosative stress levels | Very short-range; nanosecond half-life in aqueous environments |
| ¹O₂ / O₃ | Plasma discharge; photochemical | Surface antimicrobial; bacterial membrane lipid oxidation | Surface only – minimal epidermal penetration |
What distinguishes CAP RONS from endogenous pathological ROS
Three specific differences define the therapeutic character of CAP-generated RONS and explain why a treatment that generates reactive species at a wound site is mechanistically different from chronic oxidative stress:
Controlled species composition. CAP parameters – gas composition, plasma power, exposure time, device geometry – determine the ratio of ROS to RNS and the concentration of each species in the output. The H₂O₂:NO ratio in CAP output can be adjusted to favour antimicrobial (higher H₂O₂) or vasodilatory/reparative (higher NO) applications. Endogenous ROS in chronic inflammation are not compositionally controlled – they reflect whatever upstream activating pathway is driving NOX and NOS activity.
Short-lived species acting locally. ·OH, ¹O₂, and ONOO⁻ have nanosecond-to-microsecond half-lives in aqueous environments. CAP-generated versions of these species act at the tissue surface at the moment of treatment and do not accumulate systemically. Contrast with chronic low-grade oxidative stress, where longer-lived species like H₂O₂ diffuse through multiple cell layers and maintain elevated NF-κB/AP-1 signalling persistently.
Dose-titration. CAP exposure can be adjusted in real time to maintain RONS delivery within the NRF2-activation/hormetic zone rather than the NF-κB/AP-1/damage zone. The treating practitioner controls the concentration. Endogenous oxidative stress is not clinically titratable.
NRF2 activation as a CAP mechanism. The upregulation of HMOX1 and NQO1 by CAP-generated H₂O₂ is not merely a protective response to the treatment, but a pro-reparative mechanism in its own right. HMOX1 generates cytoprotective bilirubin and CO; CO at low concentrations is anti-inflammatory (suppresses NF-κB, reduces TNF-α) and vasodilatory. NQO1 stabilises p53, supporting normal apoptosis of cells that have accumulated DNA damage. The NRF2 response to CAP is therefore part of its therapeutic mechanism, not a side effect that limits it. [8] [5]
Clinical Application
RONS and the clinic’s treatment modalities
RONS are the shared mechanistic thread running through every stimulatory treatment the clinic delivers. RF microneedling generates localised thermal injury → NOX activation → H₂O₂ burst → PI3K/Akt and MAPK → fibroblast proliferation and procollagen synthesis. Thulium laser produces fractional ablation → acute ROS at ablation margins → HIF-1α/VEGF → angiogenic support of the healing zone. CAP delivers RONS directly and controllably to the tissue surface, with H₂O₂ and NO as its primary effectors. In each case, the RONS generation is not a complication of the treatment – it is how the treatment initiates the repair cascade.
The clinical consequence of understanding this is precision in two areas: client communication, and pre/post-procedure planning.
CAP – what clients are experiencing
Clients undergoing a CAP course sometimes describe an experience they find difficult to interpret: a mild warm or tingling sensation at the treatment site, occasionally a transient surface redness that resolves within an hour, and over the following days an improvement in redness and reactivity that feels disproportionate to the gentleness of the treatment. The RONS explanation makes all of this coherent.
The sensation is the direct effect of ROS and RNS on sensory nerve terminals and keratinocytes – H₂O₂ is mildly TRPV1-activating at the treatment surface concentration, which is also part of why CAP reduces TRPV1 expression over a treatment course rather than sensitising it: the controlled acute exposure at therapeutic doses activates NRF2 in sensory neurons, reducing the TRPV1 upregulation that chronic uncontrolled ROS would maintain. The progressive reduction in rosacea reactivity over a CAP course is the combined result of NF-κB modulation reducing the priming cytokine environment, antimicrobial activity reducing Demodex/bacterial RONS that was activating TRPA1 and TRPV1, and NRF2-driven cytoprotection in keratinocytes and fibroblasts. Each session is doing several things simultaneously; the RONS mechanism underpins them all.
Antioxidant supplement timing – the nuanced position
This is the clinical conversation the RONS framework most directly enables, and it requires more precision than the standard “antioxidants are good for skin” or its inverse. The relevant facts are these:
The hormetic wound response after RF microneedling, thulium laser, and CAP is initiated by the acute RONS burst at the treatment site. That burst activates NOX → H₂O₂ → PI3K/Akt, HIF-1α, NF-κB at the wound edge, and these signals drive the fibroblast proliferation, VEGF induction, and procollagen synthesis that constitute the treatment’s remodelling benefit. High-dose oral antioxidant supplementation taken immediately before or after a stimulatory procedure introduces a theoretical concern: if intracellular ROS are substantially scavenged before they can complete this signalling cascade, the hormetic initiation signal is blunted before the repair programme is fully activated.
The key word is theoretical. This mechanism is well-supported by cell-biology studies and coherent within the RONS dose-response framework – but direct RCT evidence in aesthetic procedure populations does not exist at the time of writing. The honest clinical position, consistent with the evidence hierarchy the knowledge base applies throughout:
High-dose oral supplementation where the concern is mechanistically strongest:
- N-acetylcysteine (NAC) – rapidly increases intracellular glutathione, the primary H₂O₂ scavenger; the most direct theoretical concern for blunting the wound H₂O₂ signal
- High-dose lipoic acid (>300mg oral) – regenerates both vitamin C and glutathione; similar concern
- Very high-dose oral vitamin C (>2g single dose) – at pharmacological doses, pro-oxidant effects are actually more likely than antioxidant; at physiological doses (200mg–500mg), not a concern
- High-dose astaxanthin (>12mg/day) – emerging evidence for singlet oxygen quenching; theoretical RONS suppression
What is not a concern:
- Topical vitamin C (ascorbic acid, 10–20%) applied post-procedure – actively supports the procollagen I/III mRNA upregulation cascade and collagen maturation; should be encouraged in the post-procedure recovery phase, not avoided mdpen
- Food-derived antioxidants (berries, green tea, vegetables) – concentrations do not reach tissue levels that meaningfully scavenge the acute wound RONS burst
- Standard-dose multivitamins – not a concern
- Topical vitamin E post-procedure – membrane-protective, supports barrier recovery, not suppressive of the repair cascade
The practical guidance: suggest pausing high-dose NAC and lipoic acid supplementation 48 hours before and 72 hours after stimulatory procedures. The conversation is worth having if a client mentions these specifically – not as a blanket instruction to stop all antioxidant products, which would be both inaccurate and unnecessarily alarming.
Photoprotection as RONS prevention
Broad-spectrum SPF50+ photoprotection is the most evidence-supported RONS management strategy available to every skin client regardless of condition, age, or treatment history – and framing it in RONS terms gives the recommendation a mechanistic precision that the standard “UV causes ageing” message lacks.
UV generates ·OH via the Fenton reaction from photo-released iron, ¹O₂ from endogenous photosensitisers, and activates NOX in UV-exposed keratinocytes producing O₂·⁻. All three activate AP-1 → MMP-1 → collagen I degradation, and all three contribute to the mitochondrial ROS accumulation that progressively impairs fibroblast function. Daily SPF50+ prevents this UV/ROS/AP-1/MMP cascade at source – not by neutralising ROS after generation, but by preventing the primary UV-activation event that generates them. In clients with already-sensitised skin (rosacea, post-procedure, barrier-disrupted), the reduced UV-ROS load also directly reduces TRPV1 activation and mast cell degranulation events, lowering the neurogenic and innate immune burden simultaneously.
A client who asks why photoprotection matters even on cloudy days now has an answer that goes beyond SPF numbers.
NRF2-supporting homecare – the indirect antioxidant strategy
The most durable antioxidant strategy in homecare is not exogenous antioxidant delivery – it is supporting the cell’s own NRF2-mediated defence system. Several well-evidenced ingredients operate through NRF2 activation rather than direct ROS scavenging:
- Niacinamide ( vitamin B3, 4–5%) – increases cellular NAD⁺ and NADPH availability, supporting glutathione regeneration and mitochondrial electron transport efficiency; also NF-κB modulatory; the indirect antioxidant effect is one mechanism among several for this ingredient
- Sulforaphane (from glucoraphanin in topical broccoli-derived ingredients or oral supplementation) – direct Keap1 cysteine modifier; one of the most potent dietary NRF2 activators identified; activates the full ARE-gene battery including HMOX1, NQO1, and GCL; evidence strongest for oral sulforaphane from broccoli sprout preparations [5]
- Resveratrol (topical or oral, at appropriate doses) – NRF2 activator via SIRT1-mediated Keap1 deacetylation; also activates AMPK, supporting mitochondrial biogenesis and reducing baseline mitochondrial ROS; evidence for topical efficacy limited by bioavailability issues in most formulations
- CoQ10 (ubiquinone/ubiquinol) – mitochondrial electron transport chain component; supplementation supports electron transport efficiency, reducing electron leak and O₂·⁻ generation at Complex I/III; the anti-ageing rationale for CoQ10 in skincare is specifically the mitochondrial ROS perpetuation cycle described in the skin ageing section – it addresses the source, not the downstream consequences
The distinction between NRF2-activating ingredients and direct antioxidant delivery matters because NRF2 activation amplifies the cell’s own enzymatic antioxidant system – catalase, SOD, GPx – which operates catalytically (not consumed in the reaction) and therefore provides sustained protection. Direct antioxidants (vitamin C, vitamin E) are consumed in neutralising ROS and must be continuously replenished. A homecare programme built around NRF2 support is not replacing topical antioxidants – it is working at a more upstream level alongside them.
Clinical Pearl When a client asks whether they should “take antioxidants” to protect their skin or help it recover – and this question comes up regularly – the RONS framework gives the precise answer the question actually deserves. Not “yes, antioxidants are great for skin” and not “careful, antioxidants might blunt your treatment.” The honest answer has three parts: first, the cell’s own antioxidant system, when supported through NRF2-activating ingredients and mitochondrial-supporting nutrition, is more effective and more targeted than any exogenous antioxidant can be; second, topical vitamin C post-procedure actively supports the collagen synthesis cascade and should be used, not avoided; third, if they are taking high-dose NAC or lipoic acid, there is a reasonable mechanistic case for pausing these around stimulatory procedure sessions, and the two-day window on each side of the treatment is worth noting. What this breaks down is the “free radicals bad, antioxidants good” oversimplification that has been circulating in aesthetics and wellness spaces for thirty years – and replaces it with a model where the goal is not to eliminate reactive species but to maintain them in the zone where they are working for the skin rather than against it. That is a meaningfully different frame, and clients who understand it make better decisions about their homecare.
References
Antonevich SM, Miller KM, Hu S, et al. (2026). The Mitochondrial Blueprint of Skin Aging: From Damage Signals to Dermatologic Interventions. Aging Dis . doi.org/10.14336/ad.2025.1585
Helou DG, Martin SF, Pallardy M, et al. (2019). Nrf2 Involvement in Chemical-Induced Skin Innate Immunity. Front Immunol, 10, 1004 . doi.org/10.3389/fimmu.2019.01004
Huang W, Ran J, Du Y, et al. (2026). New Insights into the Anti-Aging Mechanism of Collagen Peptides-Emphasis on Lysosomes and Mitochondria Function. Molecules, 31(5) . doi.org/10.3390/molecules31050763
Hunt M, Torres M, Bachar-Wikstrom E, et al. (2024). Cellular and molecular roles of reactive oxygen species in wound healing. Commun Biol, 7(1), 1534 . doi.org/10.1038/s42003-024-07219-w
Kim HJ, Hong JH (2026). Emerging Therapeutic Strategies for Nrf2-Associated Skin Disorders: From Photoaging to Autoimmunity. Antioxidants (Basel), 15(1) . doi.org/10.3390/antiox15010069
Luna-López A, González-Puertos VY, López-Diazguerrero NE, et al. (2014). New considerations on hormetic response against oxidative stress. J Cell Commun Signal, 8(4), 323-31 . doi.org/10.1007/s12079-014-0248-4
Nan L, Guo P, Hui W, et al. (2025). Recent advances in dermal fibroblast senescence and skin aging: unraveling mechanisms and pioneering therapeutic strategies. Front Pharmacol, 16, 1592596 . doi.org/10.3389/fphar.2025.1592596
Raissi-Dehkordi N, Raissi-Dehkordi N, Ebrahimibagha H, et al. (2025). Advancing chronic and acute wound healing with cold atmospheric plasma: cellular and molecular mechanisms, benefits, risks, and future directions. Front Med (Lausanne), 12, 1527736 . doi.org/10.3389/fmed.2025.1527736
Stout R, Birch-Machin M (2019). Mitochondria’s Role in Skin Ageing. Biology (Basel), 8(2) . doi.org/10.3390/biology8020029
Tampa M, Nicolae I, Ene CD, et al. (2024). The Interplay between Nitrosative Stress, Inflammation, and Antioxidant Defense in Patients with Lichen Planus. Antioxidants (Basel), 13(6) . doi.org/10.3390/antiox13060670
Ukaegbu K, Allen E, Svoboda KKH (2025). Reactive Oxygen Species and Antioxidants in Wound Healing: Mechanisms and Therapeutic Potential. Int Wound J, 22(5), e70330 . doi.org/10.1111/iwj.70330
Wei M, He X, Liu N, et al. (2024). Role of reactive oxygen species in ultraviolet-induced photodamage of the skin. Cell Div, 19(1), 1 . doi.org/10.1186/s13008-024-00107-z
Weller R (2003). Nitric oxide: a key mediator in cutaneous physiology. Clin Exp Dermatol, 28(5), 511-4 . doi.org/10.1046/j.1365-2230.2003.01365.x
Zaborova V, Budanova E, Kryuchkova K, et al. (2025). Nitric oxide: a gas transmitter in healthy and diseased skin. Med Gas Res, 15(4), 520-528 . doi.org/10.4103/mgr.medgasres-d-24-00144
Also Known As
- reactive species
- RONS
Learn More
This topic is discussed in 4 articles:
-

-

Discover how to restore and maintain your skin’s natural defences. From the causes of skin barrier damage to advanced treatments. Achieve healthy, radiant skin with our expert advice.
-

Hard water affects 60% of UK households and gets worse with age. Discover what actually works for your skin barrier, what doesn’t, and why your water matters more than you think.
-

A family of chemically reactive molecules containing oxygen or nitrogen, generated by cold atmospheric plasma (CAP) treatment. RONS are particularly effective against Staphylococcus aureus and its biofilm, achieving multi-log reductions in viable biofilm cells in laboratory studies. CAP also enhances macrophage killing of S. aureus including antibiotic-resistant MRSA strains through oxidative mechanisms. The mechanism accounts for CAP’s selective antimicrobial effect – reducing pathogens whilst sparing commensals – distinguishing it from broad-spectrum antibiotics.
-

A family of chemically reactive molecules containing oxygen or nitrogen, generated by cold atmospheric plasma (CAP) treatment. RONS are particularly effective against Staphylococcus aureus and its biofilm, achieving multi-log reductions in viable biofilm cells in laboratory studies. CAP also enhances macrophage killing of S. aureus including antibiotic-resistant MRSA strains through oxidative mechanisms. The mechanism accounts for CAP’s selective antimicrobial effect – reducing pathogens whilst sparing commensals – distinguishing it from broad-spectrum antibiotics.